MaxCyte Long Term Debt

MaxCyte (MXCT) currently reports a long-term debt of $16M as of June 2026. That compares with $34M in the prior-year period — down 54.3% year over year. Use the charts on this page to explore MaxCyte's long-term debt history and peer comparisons.

MaxCyte's long-term debt decreased from $34M to $16M — a 54.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

MaxCyte reported $16M in long-term debt as of June 2026. That compares with $34M in the prior-year period — down 54.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for MaxCyte, and consider following MXCT for alerts when major investors trade the stock.

MaxCyte is classified in the Materials sector. On long-term debt, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing MXCT with unrelated industries.